21718 results for «»
21718 results
What's on the Programme?
A short history of the Euro4C Group
16 Jan 2019
Who better to recount its history than the inaugural President of the Euro4C Group? Additionally, insights are provided by the Chairman of PCR, the former EAPCI President, and a pivotal member of the editorial team.
MitrAI score: machine learning models to predict mortality at 12, 24, 36 and 48 months in patients with primary and secondary MR treated by TEER
31 Aug 2024
Jonathan Curio provides his take on the MitrAI score study which was presented by Luigi Biasco at ESC Congress 2024 in London.

Author
A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension
13 Nov 2024
Lucas Lauder and Felix Mahfoud provide a summary of the ESC Guidelines on elevated blood pressure and hypertension presented by John William McEvoy and Rhian Touyz at ESC Congress 2024 in London.

Author

Author
RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
01 Sep 2024
Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.
The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...

Author
MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation
01 Sep 2024
Yohei Ohno provides his takeaways from the results of the MATTERHORN trial presented by Volker Rudolph at the ESC Congress 2024 in London.

Author
Euro4C Team
19 Jun 2024
Discover the individuals driving the Euro4C Group, including the main board, national coordinators, research and education groups, and the dedicated editorial team!
Durable-polymer versus biodegradable-polymer drug-eluting stents in acute coronary syndromes: three-year outcomes of the HOST REDUCE POLYTECH RCT Trial
20 Jun 2024
This trial found that, in ACS patients undergoing PCI, DP-DES and BP-DES had similar patient-oriented outcomes at three years, but BP-DES had higher device-oriented composite outcomes, mainly due to increased TLR risk.

Reviewer
TRI.fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation
31 Aug 2024
Alex Sticchi provides his take on the results of the TRI.FR trial presented by Erwan Donal at the ESC Congress 2024 in London.

Author
ASSURE DES - Perioperative antiplatelet therapy in patients with coronary stents before non-cardiac surgery
31 Aug 2024
Elad Asher provides his take on the ASSURE DES trial presented by Jung-Min Ahn at the ESC Congress 2024 in London.

Author
Controlled ring expansion during aortic valve-in-valve: a proof-of-concept CT-scan analysis
24 Jun 2024
Analyze this EIJ image to see how surgical aortic bioprostheses with expandable ring technology can significantly enhance future ViV procedures.
NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation
01 Sep 2024
Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.

Author

Author

Author
POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?
02 Sep 2024
Luis Ortega-Paz provides his take on the POPular PAUSE TAVI trial presented by Dirk Jan van Ginkel at the ESC Congress 2024 in London.

Author
RHEIA - Transcatheter versus surgical aortic valve replacement in women with severe aortic stenosis
01 Sep 2024
While Chiara De Biase interviews Helene Eltchaninoff about the RHEIA trial results, which she presented at the ESC Congress 2024 in London, Panos Xaplanteris shares his perspective on the trial, offering all the essential information and key takeaways you need for your practice!

Author

Author

Author
ESC Practice Guidelines 2024: chronic coronary syndromes
30 Aug 2024
Julia Grapsa provides her take on the Chronic Coronary Syndromes (CCS) Guidelines which were presented by Felicita Andreotti and Christiaan Vrints at ESC Congress 2024 in London.

Author
SENIOR-RITA - Older patients with non-ST segment elevation myocardial infarction randomised interventional treatment trial
02 Sep 2024
Mirvat Alasnag provides her take on the SENIOR-RITA trial, presented by Vijay Kunadian at the ESC Congress 2024 in London.

Author
Focus on PCR Innovators Day
18 Jun 2024 – From EuroPCR 2024
Nicole Karam and Nicolo Piazza highlighted EuroPCR 2024's PCR Innovators Day, which gathered over 400 physicians, ventures, industry partners, and investors to exchange ideas and network. Key topics included valve disease, heart failure, denervation, and the obstacles to innovation across different geographies, addressed in the innovator...
Focus on Jon DeHaan Foundation Award for Innovation in Cardiology
18 Jun 2024 – From EuroPCR 2024
Join Tom DeHaan, Rishi Puri, and Robert Schwartz as they delve into the history and purpose of the Jon DeHaan Foundation. Learn about the prestigious award's latest winner, the A-FLUX coronary sinus reducer, and the journey that led to this achievement. Discover how recognizing innovative and...
EARTH-STEMI - Complete vs. culprit-only revascularisation in older STEMI patients
03 Sep 2024
Aaysha Cader interviews Gianluca Campo about the EARTH-STEMI trial he presented at ESC Congress 2024 in London.
This meta-analysis aimed to evaluate a large cohort of STEMI patients, predominantly comorbid, with a mean age of 79 and extended long-term follow-up. The key findings revealed that complete revascularisation reduced the...

Author

Author
SCOFF - Fasting or no fasting before cardiac catherisation procedures
03 Sep 2024
Aaysha Cader interviews David Ferreira about the SCOFF trial he presented at the ESC Congress 2024 in London.
Results showed that eating normally before minimally invasive heart procedures did not increase complications and improved patient satisfaction, suggesting a need to reconsider fasting guidelines.

Author

Author